JP Morgan Maintains Neutral on Cardinal Health, Raises Price Target to $123
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Lisa Gill maintains a Neutral rating on Cardinal Health (NYSE:CAH) but raises the price target from $111 to $123.

August 21, 2024 | 2:06 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
JP Morgan has maintained a Neutral rating on Cardinal Health but increased the price target from $111 to $123, indicating a positive outlook on the stock's potential.
The increase in price target from $111 to $123 suggests that JP Morgan sees potential upside in Cardinal Health's stock, which could lead to a positive short-term impact on the stock price. However, the Neutral rating indicates a balanced view, suggesting that while there is potential for growth, there are also factors that may limit the stock's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100